Fig. 5: Vigilance stage A1 as a predictive biomarker in MDD.

Here the training set refers to the original dataset. A Logistic decision functions for responders vs. non-responders. A 50% response probability represents 36% of A1 stage (only data from 10 min-block is shown here). B ROC classification for treatment responders derived from LOOCV.